BusinessAbiomed Surpasses 50,000 Impella® Patients Treated in the United StatesBy Nasdaq OMXFeb 23, 2017, 6:59 PM UTC
BusinessSunshine Heart Announces Exchange and $3.8 Million OfferingBy Nasdaq OMXOct 31, 2016, 1:01 PM UTC
BusinessFDA allows Phrixus’s IND for Carmeseal-MD™ (P-188 NF) in Duchenne muscular dystrophy (DMD)By Nasdaq OMXSep 7, 2016, 12:00 PM UTC
